December 19, 2024

Large Acetaminophen Study Reveals New Risks

In a large cohort study of 180,483 acetaminophen users aged 65 or older, researchers found that use was associated with a 36% increased risk of lower gastrointestinal bleeding.

Conexiant

December 16, 2024

Colon Cancer's Hidden Inflammatory Signature Found

Researchers have identified a significant breakdown in the body's natural inflammation-resolution process in colorectal cancer, where tumor cells maintain a chronic inflammatory state by failing to switch from pro-inflammatory to inflammation-resolving lipids, potentially opening new therapeutic pathways.

Conexiant

December 13, 2024

MTAP Deficiency: A New Biomarker and Therapeutic Target in Aggressive Urothelial Bladder Cancer

With MTAP loss predictive of worse outcomes, researchers explore precision therapies and diagnostic advancements in bladder cancer.

Conexiant

December 11, 2024

Study Identifies Viable H. pylori in Root Canals of Infected Teeth

New study finds viable Helicobacter pylori in oral cavity root canals of endodontically infected primary teeth in children, potentially posing a risk for reinfection or transmission. Published in Cell Communication and Signaling.

Conexiant

December 06, 2024

ABSI vs. BMI: Predicting CRC Risk in Metabolic Syndrome

New study reveals that A Body Shape Index (ABSI) outperforms traditional measures in predicting colorectal cancer risk among individuals with metabolic syndrome.

Conexiant

December 03, 2024

Gluten-Free Diet Restores Key Epigenetic Marker in Coeliac Disease

LINE-1 hypomethylation, a reversible feature of Coeliac disease inflammation, offers new insights into cancer prevention.

Conexiant

December 03, 2024

FDA Greenlights Yesintek Biosimilar

Conexiant

December 02, 2024

2024 Vitamin D Guidelines: A Critical Review

"If the pharmaceutical industry had developed a single drug capable of reducing cancer mortality by 25%, autoimmune disorders by 39%, and COVID-19 infection rates by 74%, it would be heralded as a miracle drug."

Conexiant

December 02, 2024

Electric Fields Extend Pancreatic Cancer Survival: Study

Novocure's experimental therapy utilizing Tumor Treating Fields and chemotherapy has exhibited promising results in extending survival for patients with advanced pancreatic cancer.

Reuters